Skip to main content

Table 2 Clinical characteristics of deficient mismatch repair cases

From: Using a multistep approach with multidisciplinary team to increase the diagnosis rate of Lynch syndrome-associated colorectal cancer after universal screening: a single-center study in Japan

 

P-MA group

n = 26

MA group

n = 26

P-value

Age at surgery, years, n (%)

  

0.37

< 70

6 (23.1)

10 (38.5)

 

70

20 (76.9)

16 (61.5)

 

Sex, male/female

12/14

16/10

0.40

Family history of colorectal cancer, n (%)

  

0.60*

Yes

6 (23.1)

6 (23.1)

 

No

19 (73.1)

20 (76.9)

 

Unknown

1 (3.8)

0 (0)

 

Synchronous colorectal cancer, n (%)

1 (3.8)

3 (11.5)

0.61

Metachronous colorectal cancer, n (%)

4 (15.4)

4 (15.4)

1.00

Tumor location, n (%)

  

0.99*

Right colon

24 (92.3)

22 (84.6)

 

Left colon

1 (3.8)

2 (7.7)

 

Rectum

1 (3.8)

2 (7.7)

 

Tumor histology, n (%)

  

0.91**

Tubular adenocarcinoma

15 (57.7)

19 (73.1)

 

Poorly differentiated adenocarcinoma

1 (3.8)

1 (3.8)

 

Mucinous

6 (23.1)

4 (15.4)

 

Others

4 (15.4)

2 (7.7)

 

Pathological stage*, m (%)

  

0.25***

0

1 (3.8)

1 (3.8)

 

I

3 (11.5)

9 (34.6)

 

II

15 (57.7)

12 (46.2)

 

III

7 (26.9)

4 (15.4)

 

IV

0 (0)

0 (0)

 

MMRP IHC, n

  

0.97***

MLH1 and PMS2 deficient

23 (88.5)

22 (84.6)

 

MSH2 and MSH6 deficient

1 (3.8)

2 (7.7)

 

PMS2 deficient only

0 (0)

1 (3.8)

 

MSH6 deficient only

2 (7.7)

0 (0)

 

Null phenotype

0 (0)

1 (3.8)

 
  1. Pathological stage was defined according to the UICC-TNM, 8th edition
  2. MMRP, mismatch repair protein; IHC, immunohistochemistry; MA, multistep approach; P-MA, pre-multistep approach
  3. P-value < 0.05
  4. * Chi-squared test with Bonferroni correction: P-value < 0.017
  5. ** Chi-squared test with Bonferroni correction: P-value < 0.013
  6. *** Chi-squared test with Bonferroni correction: P-value < 0.010